Article metrics

  • citations in SCindeks: 0
  • citations in CrossRef:0
  • citations in Google Scholar:[=>]
  • visits in previous 30 days:6
  • full-text downloads in 30 days:6
article: 3 from 4  
Back back to result list
Vojnosanitetski pregled
2016, vol. 73, iss. 12, pp. 1094-1101
article language: English
document type: Original Scientific Paper
doi:10.2298/VSP150510134D

Creative Commons License 4.0
Psoriasis is the independent factor for early atherosclerosis: A prospective study of cardiometabolic risk profile
Dinić Miroslav Ž.a, Zečević Radoš D.b, Hajduković Zoranc, Mijušković Mirjanad, Đurić Predrage, Jović Zorane, Grdinić Aleksandrae, Petrović Mirjanad, Terzić Brankicaf, Pejović Jankog, Kandolf-Sekulović Lidijab ORCID
aVojnomedicinska akademija
bClinic of Dermatology and Venereology, Military Medical Academy, Belgrade + Faculty of Medicine of the Military Medical Academy, University of Defence, Belgrade
cFaculty of Medicine of the Military Medical Academy, University of Defence, Belgrade + Clinic of Endocrinology, Military Medical Academy, Belgrade
dFaculty of Medicine of the Military Medical Academy, University of Defence, Belgrade + Clinic of Nephrology, Military Medical Academy, Belgrade
eFaculty of Medicine of the Military Medical Academy, University of Defence, Belgrade + Clinic of Cardiology, Military Medical Academy, Belgrade
fClinic of Nephrology, Military Medical Academy, Belgrade
gFaculty of Medicine of the Military Medical Academy, University of Defence, Belgrade + Institute of Biochemistry, Military Medical Academy, Belgrade

e-mail: lkandolfsekulovic@gmail.com

Abstract

Background/Aim. Psoriasis as multisystemic inflammatory disease is related with an increased cardiometabolic risk. The aim of the study was to analyze risk biomarkers, peripheral and renal arteries ultrasonography and echocardiography for subclinical atherosclerosis and metabolic disease in 106 subjects (66 psoriasis patients and 40 controls, 20 eczema patients and 20 healthy volunteers). Methods. In all exameenes following parameters were analyzed: body mass index (BMI), C-reactive protein, D-dimer, serum amyloid A (SAA), apolipoprotein (Apo) A1, ApoB, ApoB/Apo A1 index, fasting glucose, C-peptide, fasting insulinemia, homeostatic model assessment-insulin resistance (HOMA-IR), HOMA-β-cell, lipid profile, serum uric acid concentration (SU AC), 24-h proteinuria and microalbuminuria. Carotid, brachial, femoral and renal arteries ultrasonography, as well as echocardiography was also performed. Results. Five of 66 (7.6%) psoriasis patients had metabolic syndrome (not present in both control groups). The following variables were increased in patients with psoriasis compared to both control groups: BMI (p = 0.012), insulinemia p < 0.001), HOMA-IR p = 0.003), HOMA-β cell p < 0.001), SUAC p = 0.006), ApoB/ApoA1 ratio (p = 0.006) and microalbuminuria (p < 0.001). Also, increased C-peptide (p = 0.034), D-dimer (p = 0.029), triglycerides (p = 0.044), SAA (p = 0.005) and decreased ApoA1 (p = 0.014) were found in the psoriasis patients compared to healthy controls. HDL cholesterol was decreased in the psoriasis patients compared to the control group of eczema patients (p = 0.004). Common carotid (CIMT) and femoral artery intima-media thickness (FIMT) was significantly greater (p < 0.001) and the maximal flow speed (cm/s) in brachial artery significantly decreased (p = 0.017) in the patients with psoriasis in comparison to both control groups. In multivariate logistic regression analysis, after the adjustment for confounding variables, the most important predictor of CIMT and FIMT was the diagnosis of psoriasis (p < 0.001). Conclusion. Cardiometabolic risk biomarkers and ultrasonographic signs of early atherosclerosis are correlated with the diagnosis of psoriasis, and not to generalized eczema. Psoriasis was found to be an independent risk factor for sub-clinical atherosclerosis.
For this article there is a related paper (correction, retraction, or comment) which is available here.

Keywords

psoriasis; arterial occlusive diseases; metabolic diseases; comorbidity; risk factor

References

[ CR ] [ PM ] [ EČ ][ GS ]

Akhyani, M., Ehsani, A.H., Robati, R.M., Robati, A.M. (2007) The lipid profile in psoriasis: a controlled study. Journal of the European Academy of Dermatology and Venereology, 21(10): 1330-2

[ CR ][ 1 ][ GS ]

Albareda, M., Ravella, A., Castelló, M., Saborit, S., Peramiquel, L., Vila, L. (2014) Metabolic syndrome and its components in patients with psoriasis. SpringerPlus, 3(1): 612

[ CR ] [ PM ] [ CHE ] [ EČ ][ 16 ][ GS ]

Alberti, K.G., Zimmet, P.Z. (1998) Definition, diagnosis and classification of diabetes mellitus and its complications, Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med, 15(7): 539-53

[ GS ]

Amin, T., Saied, E., Abdou, S.H. (2005) Atherosclerotic risk in psoriasis. J Pan-Arab League Dermatol, 16(2); 39-45

[ CR ] [ PM ] [ EČ ][ 1 ][ GS ]

Armstrong, A.W., Harskamp, C.T., Armstrong, E.J. (2013) Psoriasis and metabolic syndrome: a systematic review and meta-analysis of observational studies. Journal of the American Academy of Dermatology / J. Am. Acad. Dermatol., 68(4): 654-62

[ CR ] [ PM ] [ EČ ][ GS ]

Asha, K., Sharma, S.B., Singal, A., Aggarwal, A. (2014) Association of carotid intima-media thickness with leptin and apoliprotein b/apoliprotein a-I ratio reveals imminent predictors of subclinical atherosclerosis in psoriasis patients. Acta medica (Hradec Kralove) / Acta Medica (Hradec Kralove), 57(1): 21-7

[ CR ][ GS ]

Aurangabadkar, S. (2013) Comorbidities in psoriasis. Indian Journal of Dermatology, Venereology, and Leprology, 79(7): 10

[ EČ ][ GS ]

Bajaj, D.R., Mahesar, S.M., Devrajani, B.R., Iqbal, M.P. (2009) Lipid profile in patients with psoriasis presenting at Liaquat University Hospital Hyderabad. J Pak Med Assoc, 59(8); 512-5

[ CR ] [ PM ] [ CHE ] [ EČ ][ 4 ][ GS ]

Balkau, B., Charles, M.A. (1999) Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med, 16(5): 442-3

[ CR ] [ EČ ][ GS ]

Biyik, I., Narin, A., Bozok, M., Ergene, O. (2006) Echocardiographic and Clinical Abnormalities in Patients with Psoriasis. Journal of International Medical Research, 34(6): 632-639

[ CR ] [ PM ] [ EČ ][ GS ]

Boehncke, S., Thaci, D., Beschmann, H., Ludwig, R.J., Ackermann, H., Badenhoop, K., Boehncke, W. (2007) Psoriasis patients show signs of insulin resistance. British journal of dermatology / Br. J. Dermatol., 157(6): 1249-51

[ CR ] [ PM ] [ EČ ][ GS ]

Boehncke, W., Boehncke, S., Tobin, A., Kirby, B. (2011) The 'psoriatic march': a concept of how severe psoriasis may drive cardiovascular comorbidity. Experimental dermatology / Exp. Dermatol., 20(4): 303-7

[ CR ] [ PM ] [ EČ ][ 4 ][ GS ]

Cameron, A.J., Shaw, J.E., Zimmet, P.Z. (2004) The metabolic syndrome: Prevalence in worldwide populations. Endocrinol Metab Clin North Am, 33(2): 351-75

[ EČ ][ GS ]

Cassano, N., Vestita, M., Panaro, M., Carbonara, M., Vena, G.A. (2011) Renal function in psoriasis patients. Eur J Dermatol, 21(2); 264-5

[ CR ] [ PM ] [ EČ ][ 1 ][ GS ]

Chodorowska, G., Wojnowska, D., Juszkiewicz-Borowiec, M. (2004) C-reactive protein and alpha2-macroglobulin plasma activity in medium-severe and severe psoriasis. Journal of the European Academy of Dermatology and Venereology, 18(2): 180-3

[ CR ] [ EČ ][ GS ]

Choudhury, R. P., Leyva, F. (1999) C-Reactive Protein, Serum Amyloid A Protein, and Coronary Events. Circulation, 100(15): e65-e65

[ CR ] [ PM ] [ EČ ][ GS ]

Coimbra, S., Oliveira, H., Reis, F., Belo, L., Rocha, S., Quintanilha, A., Figueiredo, A., Teixeira, F., Castro, E., Rocha-Pereira, P., Santos-Silva, A. (2009) Circulating levels of adiponectin, oxidized LDL and C-reactive protein in Portuguese patients with psoriasis vulgaris, according to body mass index, severity and duration of the disease. Journal of dermatological science / J. Dermatol. Sci., 55(3): 202-4

[ CR ] [ PM ] [ EČ ][ GS ]

Dervisoglu, E., Akturk, A.S., Yildiz, K., Kiran, R., Yilmaz, A. (2012) The spectrum of renal abnormalities in patients with psoriasis. International urology and nephrology / Int Urol Nephrol, 44(2): 509-14

[ CR ] [ PM ] [ EČ ][ GS ]

Detection, E.P.on, Adults and Treatment of High Blood Cholesterol (2001) Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA: The Journal of the American Medical Association, 285(19): 2486-2497

[ CR ] [ PM ] [ EČ ][ GS ]

Dogan, S., Atakan, N. (2010) Is serum amyloid A protein a better indicator of inflammation in severe psoriasis?. British journal of dermatology / Br. J. Dermatol., 163(4): 895-6

[ CR ] [ PM ] [ EČ ][ GS ]

El-Mongy, S., Fathy, H., Abdelaziz, A., Omran, E., George, S., Neseem, N., El-Nour, N. (2010) Subclinical atherosclerosis in patients with chronic psoriasis: a potential association. Journal of the European Academy of Dermatology and Venereology, 24(6): 661-6

[ CR ] [ PM ] [ EČ ][ GS ]

Essiarab, F., Taki, H., Lebrazi, H., Derouiche, A., Kettani, A., Sabri, M., Saile, R., Essiarab, F., Taki, H., Lebrazi, H., Derouiche, A., Kettani, A., Sabri, M., Saile, R. (2014) Inflammation and cardiovascular risk assessment in Moroccan obese patients with and without metabolic syndrome: importance of lipoproteins ratios. Ethnicity & disease / Ethn Dis, 24(4): 462-8

[ EČ ][ GS ]

Frank, P.G., Marcel, Y.L. (2000) Apolipoprote in A-I: structurefunction relationships. J Lipid Res, 41(6); 853-72

[ CR ] [ PM ] [ EČ ][ GS ]

Gelfand, J.M., Neimann, A.L., Shin, D.B., Wang, X., Margolis, D.J., Troxel, A.B. (2006) Risk of myocardial infarction in patients with psoriasis. JAMA / JAMA, 296(14): 1735-41

[ CR ] [ EČ ][ GS ]

Gonzalez-Juanatey, C., Amigo-Diaz, E., Miranda-Filloy, J.A., Testa, A., Revuelta, J., Garcia-Porrua, C., Martin, J., Llorca, J., Gonzalez-Gay, M.A. (2006) Lack of Echocardiographic and Doppler Abnormalities in Psoriatic Arthritis Patients Without Clinically Evident Cardiovascular Disease or Classic Atherosclerosis Risk Factors. Seminars in Arthritis and Rheumatism, 35(5): 333-339

[ CR ] [ PM ] [ EČ ][ GS ]

Grzybowski, G., Fafara, I., Zaba, R., Wierusz-Wysocka, B. (2001) Evaluation of glucose, insulin, C-peptide uric acid serum levels in patients with psoriasis. Polski merkuriusz lekarski, 11(66): 495-8

[ CR ] [ EČ ][ GS ]

Hamminga, E.A., van der Lely, A.J., Neumann, H.A.M., Thio, H.B. (2006) Chronic inflammation in psoriasis and obesity: Implications for therapy. Medical Hypotheses, 67(4): 768-773

[ CR ] [ EČ ][ GS ]

Javidi, Z., Meibodi, N., Nahidi, Y. (2007) Serum lipids abnormalities and psoriasis. Indian Journal of Dermatology, 52(2): 89

[ CR ] [ EČ ][ GS ]

Jensen, P., Zachariae, C., Hansen, P., Skov, L. (2011) Normal Endothelial Function in Patients with Mild-to-Moderate Psoriasis: A Case-control Study. Acta Dermato Venereologica, 91(5): 516-520

[ CR ] [ PM ] [ EČ ][ GS ]

Karoli, R., Fatima, J., Shukla, V., Dhillon, K.S., Khanduri, S., Maini, S., Chandra, A. (2013) A study of cardio-metabolic risk profile in patients with psoriasis. Journal of the Association of Physicians of India / J Assoc Physicians India, 61(11): 798-803

[ CR ] [ EČ ][ GS ]

Kural, B.V., Örem, A., Çimşit, G., Yandı, Y.E., Calapoǧlu, M. (2003) Evaluation of the atherogenic tendency of lipids and lipoprotein content and their relationships with oxidant–antioxidant system in patients with psoriasis. Clinica Chimica Acta, 328(1-2): 71-82

[ CR ] [ EČ ][ GS ]

Lowes, M.A., Kikuchi, T., Fuentes-Duculan, J., Cardinale, I., Zaba, L.C., Haider, A.S., Bowman, E.P., Krueger, J.G. (2008) Psoriasis Vulgaris Lesions Contain Discrete Populations of Th1 and Th17 T Cells. Journal of Investigative Dermatology, 128(5): 1207-1211

[ CR ] [ PM ] [ EČ ][ GS ]

Marongiu, F., Sorano, G.G., Bibbò, C., Pistis, M.P., Conti, M., Mulas, P., Balestrieri, A., Biggio, P. (1994) Abnormalities of blood coagulation and fibrinolysis in psoriasis. Dermatology (Basel, Switzerland) / Dermatology (Basel), 189(1): 32-7

[ CR ] [ PM ] [ EČ ][ GS ]

Meigs, J.B., Wilson, P.W.F., Fox, C.S., Vasan, R.S., Nathan, D.M., Sullivan, L.M., D`Agostino, R.B. (2006) Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. Journal of clinical endocrinology and metabolism, 91(8): 2906-12

[ CR ] [ PM ] [ EČ ][ GS ]

Menter, A., Gottlieb, A., Feldman, S.R., van Voorhees, A.S., Leonardi, C.L., Gordon, K.B., Lebwohl, M., Koo, J.Y.M., Elmets, C.A., Korman, N.J., Beutner, K.R., Bhushan, R. (2008) Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. Journal of the American Academy of Dermatology / J. Am. Acad. Dermatol., 58(5): 826-50

[ CR ] [ EČ ][ GS ]

Moller, D.E., Kaufman, K.D. (2005) Metabolic Syndrome: A Clinical and Molecular Perspective. Annual Review of Medicine, 56(1): 45-62

[ CR ] [ PM ] [ EČ ][ GS ]

Naldi, L., Chatenoud, L., Linder, D., Fortina, A.B., Peserico, A., Virgili, A.R., Bruni, P.L., Ingordo, V., Scocco, G.L., Solaroli, C., Schena, D., Barba, A., di Landro, A., Pezzarossa, E. (2005) Cigarette Smoking, Body Mass Index, and Stressful Life Events as Risk Factors for Psoriasis: Results from an Italian Case–Control Study. Journal of Investigative Dermatology, 125(1): 61-67

[ CR ] [ PM ] [ EČ ][ 1 ][ GS ]

Neimann, A.L., Shin, D.B., Wang, X., Margolis, D.J., Troxel, A.B., Gelfand, J.M. (2006) Prevalence of cardiovascular risk factors in patients with psoriasis. Journal of the American Academy of Dermatology / J. Am. Acad. Dermatol., 55(5): 829-35

[ CR ] [ PM ] [ EČ ][ GS ]

Ohtsuka, T. (2008) The relation between high-sensitivity C-reactive protein and maximum body mass index in patients with psoriasis. British journal of dermatology / Br. J. Dermatol., 158(5): 1141-3

[ GS ]

Pietrzak, J., Chodorowska, G. (2010) Psoriasis and serum lipid abnormalities. Derma. tol Ther, 23(2): 160-73

[ CR ] [ EČ ][ GS ]

Reich, K. (2012) The concept of psoriasis as a systemic inflammation: implications for disease management. Journal of the European Academy of Dermatology and Venereology, 26: 3-11

[ CR ] [ PM ] [ EČ ][ GS ]

Reynoso-von, D.C., Martínez-Abundis, E., Balcázar-Muñoz, B.R., Bustos-Saldaña, R., González-Ortiz, M. (2003) Lipid profile, insulin secretion, and insulin sensitivity in psoriasis. Journal of the American Academy of Dermatology / J. Am. Acad. Dermatol., 48(6): 882-5

[ CR ] [ EČ ][ GS ]

Rocha-Pereira, P., Santos-Silva, A., Rebelo, I., Figueiredo, A., Quintanilha, A., Teixeira, F. (2001) Dislipidemia and oxidative stress in mild and in severe psoriasis as a risk for cardiovascular disease. Clinica Chimica Acta, 303(1-2): 33-39

[ CR ] [ EČ ][ GS ]

Schiffrin, E.L. (2002) Beyond blood pressure: the endothelium and atherosclerosis progression*. American Journal of Hypertension, 15(S5): 115S-122S

[ CR ] [ PM ] [ EČ ][ GS ]

Sergeant, A., Makrygeorgou, A., Chan, W.C., Thorrat, A., Burden, D., Walker, S.L., Kahawita, I. (2008) C-reactive protein in psoriasis. British journal of dermatology / Br. J. Dermatol., 158(2): 417-9

[ CR ] [ PM ] [ EČ ][ GS ]

Shapiro, J., Cohen, A.D., Weitzman, D., Tal, R., David, M. (2012) Psoriasis and cardiovascular risk factors: a case-control study on inpatients comparing psoriasis to dermatitis. Journal of the American Academy of Dermatology / J. Am. Acad. Dermatol., 66(2): 252-8

[ CR ] [ PM ] [ EČ ][ GS ]

Shirai, K. (2004) Obesity as the core of the metabolic syndrome and the management of coronary heart disease. Current medical research and opinion / Curr Med Res Opin, 20(3): 295-304

[ CR ] [ PM ] [ EČ ][ 1 ][ GS ]

Sommer, D.M., Jenisch, S., Suchan, M., Christophers, E., Weichenthal, M. (2006) Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Archives of dermatological research / Arch. Dermatol. Res., 298(7): 321-8

[ CR ] [ EČ ][ GS ]

Sterry, W., Strober, B.E., Menter, A., on behalf of the International Psoriasis Council (2007) Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review. British Journal of Dermatology, 157(4): 649-655

[ CR ] [ PM ] [ EČ ][ GS ]

Strober, B., Teller, C., Yamauchi, P., Miller, J.L., Hooper, M., Yang, Y., Dann, F. (2008) Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis. British journal of dermatology / Br. J. Dermatol., 159(2): 322-30

[ CR ] [ PM ] [ EČ ][ GS ]

Su, V.Y., Chen, T., Yeh, C., Chou, K., Hung, M., Chu, S., Su, K., Chang, Y., Lin, Y., Liu, C. (2014) Atopic dermatitis and risk of ischemic stroke: a nationwide population-based study. Annals of medicine / Ann. Med., 46(2): 84-9

[ CR ] [ PM ] [ EČ ][ GS ]

Viazzi, F., Leoncini, G., Derchi, L.E., Pontremoli, R. (2014) Ultrasound Doppler renal resistive index: a useful tool for the management of the hypertensive patient. Journal of hypertension / J. Hypertens., 32(1): 149-53

[ CR ] [ PM ] [ EČ ][ GS ]

Wakkee, M., Thio, H.B., Prens, E.P., Sijbrands, E.J.G., Neumann, H.A.M. (2007) Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients. Atherosclerosis / Atherosclerosis, 190(1): 1-9

[ CR ] [ PM ] [ EČ ][ 4 ][ GS ]

Wallace, T.M., Levy, J.C., Matthews, D.R. (2004) Use and abuse of HOMA modeling. Diabetes care / Diabetes Care, 27(6): 1487-95

[ CR ] [ EČ ][ GS ]

Wan, J., Wang, S., Haynes, K., Denburg, M. R., Shin, D. B., Gelfand, J. M. (2013) Risk of moderate to advanced kidney disease in patients with psoriasis: population based cohort study. BMJ, 347(oct15 7): f5961-f5961

[ CR ] [ EČ ][ GS ]

Wannamethee, S. G., Shaper, A. G., Lennon, L., Morris, R.W. (2005) Metabolic Syndrome vs Framingham Risk Score for Prediction of Coronary Heart Disease, Stroke, and Type 2 Diabetes Mellitus. Archives of Internal Medicine, 165(22): 2644

[ CR ] [ EČ ][ GS ]

Wellen, K.E., Hotamisligil, G.S. (2005) Inflammation, stress, and diabetes. Journal of Clinical Investigation, 115(5): 1111-1119

[ CR ] [ PM ] [ EČ ][ GS ]

Yang, Y., Keller, J.J., Lin, H. (2011) Medical comorbidity associated with psoriasis in adults: a population-based study. British journal of dermatology / Br. J. Dermatol., 165(5): 1037-43